Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
X. Jais (Le Kremlin-Bicêtre, France), P. Brenot (Le Plessis robinson, France), H. Bouvaist (Grenoble, France), M. Canuet (Strasbourg, France), C. Chabanne (Rennes, France), A. Chaouat (Nancy, France), V. Cottin (Bron, France), P. De Groote (Lille, France), C. Dromer (Bordeaux, France), N. Favrolt (Dijon, France), C. Garcia Alonso (Le Plessis Robinson, France), B. Gérardin (Le Plessis Robinson, France), D. Horeau-Langlard (Nantes, France), M. Jevnikar (Le Kremlin-Bicêtre, France), P. Magro (Tours, France), D. Montani (Le Kremlin-Bicêtre, France), F. Parent (Le Kremlin-Bicêtre, France), C. Pison (Grenoble, France), G. Prévot (Toulouse, France), S. Renard (Marseille, France), L. Savale (Le Kremlin-Bicêtre, France), A. Simon (Poitiers, France), O. Sitbon (Le Kremlin-Bicêtre, France), R. Tresorier (Clermont-Ferrand, France), C. Tromeur (Brest, France), H. Agostini (Le Kremlin-Bicêtre, France), C. Piedvache (Le Kremlin-Bicêtre, France), E. Fadel (Le Plessis Robinson, France), M. Humbert (Le Kremlin-Bicêtre, France), G. Simonneau (Le Kremlin-Bicêtre, France). Late Breaking Abstract - Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension: results from the randomised controlled RACE study. 1885

Member's Comments

Colm McCabe - 21.04.2022 15:06
nil

Related content which might interest you: Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience Source: Eur Respir J, 49 (6) 1602409; 10.1183/13993003.02409-2016 Year: 2017 Macitentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH): results from the randomised controlled MERIT study Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017 Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind? Source: Eur Respir J, 54 (4) 1901639; 10.1183/13993003.01639-2019 Year: 2019 Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind? Source: Eur Respir J, 53 (5) 1900843; 10.1183/13993003.00843-2019 Year: 2019 Multi-step therapy with riociguat, balloon pulmonary angioplasty, and cardiac rehabilitation for inoperable chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Efficacy of riociguat in patients with inoperable CTEPH vs persistent/recurrent PH after pulmonary endarterectomy (PEA): Results from the phase III CHEST-1 study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Pulmonary angioplasty vs exclusive medical treatment in inoperable chronic thromboembolic hypertension–initial outcomes from a pulmonary hypertension centre Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Right ventricular reverse remodeling after balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology Year: 2014 Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (5) 1802095; 10.1183/13993003.02095-2018 Year: 2019 Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2014; 23: 393-395 Year: 2014 Balloon pulmonary angioplasty (BPA) for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Upfront combination therapy in the treatment of scleroderma-associated pulmonary arterial hypertension: Results of an open label trial Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension (CTEPH) as early follow-up treatment after pulmonary endarterectomy (PEA) – a prospective cohort study Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2015; 24: 263-271 Year: 2015 Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (CTEPH): does it perform as well as we hoped? Source: International Congress 2018 – New trends in the management of pulmonary hypertension Year: 2018 Open label study of bosentan in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 706s Year: 2004 Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010 Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases Year: 2019 Long-term safety and clinical effects of riociguat in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: Interim analysis of a phase II extension study Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010